Theratechnologies Inc. (TSE:TH – Get Free Report) passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of C$4.47 and traded as low as C$4.36. Theratechnologies shares last traded at C$4.47, with a volume of 35,472 shares.
Theratechnologies Price Performance
The stock has a market cap of C$205.53 million, a PE ratio of -23.53, a price-to-earnings-growth ratio of -8.50 and a beta of 0.26. The stock’s fifty day moving average is C$4.47 and its 200-day moving average is C$4.47. The company has a debt-to-equity ratio of -156.22, a current ratio of 0.84 and a quick ratio of 0.64.
Theratechnologies Company Profile
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.
Further Reading
- Five stocks we like better than Theratechnologies
- Confidence Is Back, But Earnings Show the Consumer Is Being Picky
- AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off
- 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative?
- 3 Photonics Companies Making Quantum Tech Possible
Receive News & Ratings for Theratechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies and related companies with MarketBeat.com's FREE daily email newsletter.
